TG Therapeutics, Inc.
USD40.11
+3.47 (+9.47%)
CEO
Michael S. Weiss
IPO Date
2010-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.65
Prev. Close
$36.64
Day Low
$37.96
Day High
$41.34
52W Low
$25.28
52W High
$44.65
Market Cap
$6.14B
Volume
3.62M
| 30,000 |
| $0.00 |
| 9 Jan 2026 | WEISS MICHAEL S | director, officer: CEO | A-Award | Acquired | 622,000 | $0.00 |
| 9 Jan 2026 | Power Sean A | CFO | A-Award | Acquired | 90,000 | $0.00 |
| 25 Nov 2025 | Echelard Yann | director | S-Sale | Disposed | 5,000 | $32.57 |
| 7 Nov 2025 | WEISS MICHAEL S | director, officer: CEO | G-Gift | Disposed | 3,865,126 | $0.00 |
| 7 Nov 2025 | WEISS MICHAEL S | director, officer: CEO | G-Gift | Disposed | 803,717 | $0.00 |
| 12 Sept 2025 | Lonial Sagar | director | S-Sale | Disposed | 20,852 | $32.24 |
| 16 Jun 2025 | Echelard Yann | director | S-Sale | Disposed | 10,000 | $36.94 |
| 16 Jun 2025 | Echelard Yann | director | A-Award | Acquired | 14,718 | $0.00 |